Skip to main content

Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis

Publication ,  Conference
Shao, R; Yan, W; Pazik, B; Pendergast, AM; Wang, X-F
Published in: CANCER RESEARCH
April 1, 2006

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 1, 2006

Volume

66

Issue

8

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shao, R., Yan, W., Pazik, B., Pendergast, A. M., & Wang, X.-F. (2006). Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. In CANCER RESEARCH (Vol. 66). AMER ASSOC CANCER RESEARCH.
Shao, Rong, Wei Yan, Brooke Pazik, Ann Marie Pendergast, and Xiao-Fan Wang. “Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis.” In CANCER RESEARCH, Vol. 66. AMER ASSOC CANCER RESEARCH, 2006.
Shao R, Yan W, Pazik B, Pendergast AM, Wang X-F. Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2006.
Shao, Rong, et al. “Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis.” CANCER RESEARCH, vol. 66, no. 8, AMER ASSOC CANCER RESEARCH, 2006.
Shao R, Yan W, Pazik B, Pendergast AM, Wang X-F. Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2006.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 1, 2006

Volume

66

Issue

8

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis